Li et al. found that antibodies against IL17A were less effective than dexamethasone (as positive control) in the treatment of psoriasis induced by IMQ, suggesting IL17A plays only a limited role in psoriasis pathogenesis, as dexamethasone suppressed overall inflammation [21]. This evidence concerns the gene IL17A and psoriasis.